Updated:
Catapult Ventures Group
Catapult Ventures Group is a UK-based independent fund manager that has operated discrete venture capital funds totalling approximately £130m on behalf of...
Catapult Ventures Group
Catapult Ventures Group is a UK-based independent fund manager that has operated discrete venture capital funds totalling approximately £130m on behalf of public and private sector backers. The firm draws on a tenured executive team — including Duncan Cameron, Professor Rob Carroll, Dr Tony Flinn, and Kevin D'Silva — with experience spanning healthcare, pharmaceuticals, luxury consumer, manufacturing, and software. Its Spalding headquarters is complemented by a North West office. The firm invests from seed and start-up through expansion, late stage, and management buyouts. Executives rotate lead responsibility based on who can add the most value, serving as active board members and engaging in senior hiring, customer introductions, and banking relationships. Since 2015, Catapult has recorded 15 profitable exits averaging a 4.6x money multiple — notable realisations include R2C Online at 12.6x, Accutronics at 9.1x, Yospace at 6.9x, and Oxford Cryosystems at 5.2x. The portfolio spans the UK across diagnostics, digital healthcare, biotechnology, industrial technologies, and consumer brands. Catapult lists eight executive team members and four administration professionals, reflecting a lean operating structure. No LinkedIn presence is captured, and the firm does not publicly disclose current AUM. The team emphasizes long-term value creation through deep portfolio engagement rather than passive fund-of-funds allocation. The administration unit — Sarah Cooper, Anne Freeman, Corinne Lawrence, and Natalie Melvin — each contributes more than a decade of venture capital back-office experience. The structural distinction lies in its executive-to-company matching model: there is no pooled investment committee filter that distances decision-makers from boards. A partner is attached to each holding based on sector and stage fit, directly embedding financial strategy and operational guidance. This makes Catapult function less like a traditional blinded fund manager and more like a distributed group of embedded operating partners.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Spalding
Corporate office
Otway House, 34 Spalding Road, Pinchbeck, Spalding, PE11 3UD, United Kingdom
Additional offices
North West Office, United Kingdom
Principals
Duncan Cameron
Executive Team
Professor Rob Carroll
Executive Team
Dr Tony Flinn
Executive Team
Kevin D'Silva
Executive Team
Dr Gareth King
Executive Team
Laurence Vaughan
Executive Team
Dr David Whitcombe
Executive Team
Nick Wright
Executive Team
Sector focus
Frequently asked questions
How does Catapult Ventures Group assign portfolio responsibility?
Portfolio responsibility is assigned to the executive team member who can add the most value to a given company, based on sector and stage expertise. That person serves as an active board member, involved in strategy, senior hiring, customer introductions, and financial structuring. The firm describes this as a relationship-driven model rather than a pooled investment committee approach.
What investment stages does Catapult Ventures Group target?
The firm covers the full spectrum from seed and start-up to growth capital, expansion, management buy-ins, and management buyouts. It also participates in co-investment and general venture. This staging is supported by a track record of pre-revenue IP development all the way through to company floatation.
Who runs investment decisions at Catapult Ventures Group?
A team of eight named executives leads investment decisions, including Duncan Cameron, Professor Rob Carroll, Dr Tony Flinn, and Kevin D'Silva. The firm emphasizes that each executive has direct portfolio responsibility, rather than filtering decisions through a detached central committee.
Does Catapult Ventures Group participate in fund commitments or primarily direct deals?
Catapult operates discrete venture capital funds — historically totalling approximately £130m — into which public and private sector investors commit. Within those vehicles, the team makes direct equity investments and co-investments, and actively manages portfolio companies through board seats.
What is Catapult Ventures Group's track record on exits?
Since 2015, the firm reports 15 profitable exits averaging 4.6x money multiple. Disclosed realisations include R2C Online (12.6x), Accutronics (9.1x), Yospace (6.9x), Oxford Cryosystems (5.2x), Systems Integration (4.9x), and Lumora (4.7x). Additional exits are listed on the firm's 'Selected Realised' page.
Which sectors does Catapult Ventures Group explicitly avoid?
The firm does not publish an explicit exclusions list. Its disclosed focus areas include healthcare, pharmaceuticals, diagnostics, biotechnology, medical devices, consumer, industrial and environmental technologies, and software. Sectors outside these areas may not receive active coverage.
How does Catapult Ventures Group source proprietary deal flow?
Catapult relies on the deep sector networks of its long-tenured executive team, many of whom have decades of UK venture experience. The active board model — where partners embed in portfolio companies — also generates downstream co-investment referrals and management relationships across healthcare, industrial tech, and software.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: